Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection.

Riou C, Bunjun R, Müller TL, Kiravu A, Ginbot Z, Oni T, Goliath R, Wilkinson RJ, Burgers WA.

Tuberculosis (Edinb). 2016 Dec;101:25-30. doi: 10.1016/j.tube.2016.07.018.

PMID:
27865393
2.

Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas.

Diedrich CR, O'Hern J, Gutierrez MG, Allie N, Papier P, Meintjes G, Coussens AK, Wainwright H, Wilkinson RJ.

J Infect Dis. 2016 Nov 1;214(9):1309-1318.

3.

HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response.

Hu H, Liu F, Kim J, Ratto-Kim S.

Expert Rev Vaccines. 2016 Jun;15(6):709-17. doi: 10.1586/14760584.2016.1147354.

PMID:
26814372
4.

PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.

Pollock KM, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A.

PLoS One. 2016 Jan 12;11(1):e0146905. doi: 10.1371/journal.pone.0146905.

5.

New Insights about Treg and Th17 Cells in HIV Infection and Disease Progression.

Valverde-Villegas JM, Matte MC, de Medeiros RM, Chies JA.

J Immunol Res. 2015;2015:647916. doi: 10.1155/2015/647916. Review.

6.

HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.

Lai RP, Meintjes G, Wilkinson RJ.

Semin Immunopathol. 2016 Mar;38(2):185-98. doi: 10.1007/s00281-015-0532-2.

7.

Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.

Mzinza DT, Sloan DJ, Jambo KC, Shani D, Kamdolozi M, Wilkinson KA, Wilkinson RJ, Davies GR, Heyderman RS, Mwandumba HC.

Tuberculosis (Edinb). 2015 Jul;95(4):463-9. doi: 10.1016/j.tube.2015.05.009.

8.

Maturation and Mip-1β Production of Cytomegalovirus-Specific T Cell Responses in Tanzanian Children, Adolescents and Adults: Impact by HIV and Mycobacterium tuberculosis Co-Infections.

Portevin D, Moukambi F, Mpina M, Bauer A, Haraka F, Chachage M, Metzger P, Saathoff E, Clowes P, Ntinginya NE, Rachow A, Hoelscher M, Reither K, Daubenberger CA, Geldmacher C.

PLoS One. 2015 May 14;10(5):e0126716. doi: 10.1371/journal.pone.0126716.

9.

Attrition of TCR Vα7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression.

Saeidi A, Tien Tien VL, Al-Batran R, Al-Darraji HA, Tan HY, Yong YK, Ponnampalavanar S, Barathan M, Rukumani DV, Ansari AW, Velu V, Kamarulzaman A, Larsson M, Shankar EM.

PLoS One. 2015 Apr 20;10(4):e0124659. doi: 10.1371/journal.pone.0124659.

10.

Co-infection with Mycobacterium tuberculosis impairs HIV-Specific CD8+ and CD4+ T cell functionality.

Chetty S, Govender P, Zupkosky J, Pillay M, Ghebremichael M, Moosa MY, Ndung'u T, Porichis F, Kasprowicz VO.

PLoS One. 2015 Mar 17;10(3):e0118654. doi: 10.1371/journal.pone.0118654.

11.

Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool.

Karp CL, Wilson CB, Stuart LM.

Immunol Rev. 2015 Mar;264(1):363-81. doi: 10.1111/imr.12270. Review.

12.

Impaired degranulation and proliferative capacity of Mycobacterium tuberculosis-specific CD8+ T cells in HIV-infected individuals with latent tuberculosis.

Kalokhe AS, Adekambi T, Ibegbu CC, Ray SM, Day CL, Rengarajan J.

J Infect Dis. 2015 Feb 15;211(4):635-40. doi: 10.1093/infdis/jiu505.

13.

Latent tuberculosis infection: myths, models, and molecular mechanisms.

Dutta NK, Karakousis PC.

Microbiol Mol Biol Rev. 2014 Sep;78(3):343-71. doi: 10.1128/MMBR.00010-14. Review.

14.

Immunology of tuberculosis.

Bozzano F, Marras F, De Maria A.

Mediterr J Hematol Infect Dis. 2014 Apr 7;6(1):e2014027. doi: 10.4084/MJHID.2014.027. Review.

15.

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.

Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N.

Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. Review.

16.

Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patients.

Toossi Z, Wu M, Liu S, Hirsch CS, Walrath J, van Ham M, Silver RF.

AIDS. 2014 Mar 13;28(5):679-87. doi: 10.1097/QAD.0000000000000192.

17.

Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication.

Bernier A, Cleret-Buhot A, Zhang Y, Goulet JP, Monteiro P, Gosselin A, DaFonseca S, Wacleche VS, Jenabian MA, Routy JP, Tremblay C, Ancuta P.

Retrovirology. 2013 Dec 21;10:160. doi: 10.1186/1742-4690-10-160.

18.

T cell susceptibility to HIV influences outcome of opportunistic infections.

Saharia KK, Koup RA.

Cell. 2013 Oct 24;155(3):505-14. doi: 10.1016/j.cell.2013.09.045.

19.

Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection.

Pitabut N, Sakurada S, Tanaka T, Ridruechai C, Tanuma J, Aoki T, Kantipong P, Piyaworawong S, Kobayashi N, Dhepakson P, Yanai H, Yamada N, Oka S, Okada M, Khusmith S, Keicho N.

Int J Med Sci. 2013 Jun 15;10(8):1003-14. doi: 10.7150/ijms.6437.

20.

HIV and co-infections.

Chang CC, Crane M, Zhou J, Mina M, Post JJ, Cameron BA, Lloyd AR, Jaworowski A, French MA, Lewin SR.

Immunol Rev. 2013 Jul;254(1):114-42. doi: 10.1111/imr.12063. Review.

Items per page

Supplemental Content

Support Center